ESR1 and cancer: Studies have shown that ESR1 mutations are rare in the initial stage of cancer (<1%), and most of them occur in the metastatic stage.[69] Clinical studies have shown that ESR1 mutation can preexist in the primary tumor and be enriched in the process of metastasis.